Skip to content

Prognostic disclosure in the palliative phase of breast cancer: Quality of communication from a patient perspective.

Prognostic disclosure in the palliative phase of breast cancer: Quality of communication from a patient perspective. - Prognostic disclosure in the palliative phase of breast cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON36591
Enrollment
330
Registered
2010-03-23
Start date
2010-05-12
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer maligne mamma-carcinoom

Interventions

Stuy 1: observation-design: focus groups and interviews Study 2: experiment: 4 video-vignettes are viewed . Add-on study: 1 video-vignette is viewed.

Sponsors

NIVEL
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Study 1 + 2: breast cancer survivors: women between 18-65, minimally 5 years disease-free, speak fluent Dutch, members of Dutch Breast Cancer Organisation. healthy women: women between 18 and 65, speak fluent Dutch. add-on study: healthy women between 18-65, fluent in Dutch

Exclusion criteria

Exclusion criteria: Study 1 + 2: breast cancer survivors: less than 5 years disease free. healthy women: women who are cancer survivors.;Add-on study: women who are cancer survivors.

Design outcomes

Primary

MeasureTime frame
Study 1: Qualitative data - opinions concerning the disclosure of a palliative prognosis and the role of hope and explicitness herein. Study 2: Experiment: anxiety- and uncertainty reduction Add-on study: Emotional arousal and recall are the main study parameters of this pilot study. Emotional arousal will be measured with physiological responses (heart rate and skin conductance). Recall is assessed as the number of correctly recognized or recalled information elements (both primed and free recall) will be measured.

Secondary

MeasureTime frame
Study 2: Experiment: satisfaction, self efficacy Focusgroups: qualitative data - opinions concerning the specific communication elements. Add-on study: same as main study. Extra: positive & negative affect.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)